Karin Hofmann

1.1k total citations
31 papers, 773 citations indexed

About

Karin Hofmann is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Karin Hofmann has authored 31 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Karin Hofmann's work include Neuroendocrine Tumor Research Advances (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Pediatric Urology and Nephrology Studies (4 papers). Karin Hofmann is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Pediatric Urology and Nephrology Studies (4 papers). Karin Hofmann collaborates with scholars based in Germany, Austria and United States. Karin Hofmann's co-authors include P Stieber, Peter Rehder, Bernhard Glodny, Johannes Petersen, U Hasholzner, Hendrik Dienemann, Alexander Strasak, Dorothea Nagel, A. Fateh‐Moghadam and Thomas Trieb and has published in prestigious journals such as Blood, Cancer and British Journal of Urology.

In The Last Decade

Karin Hofmann

29 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Hofmann Germany 13 217 211 171 163 146 31 773
Karel Kithier United States 15 172 0.8× 85 0.4× 213 1.2× 102 0.6× 108 0.7× 41 778
Emmanuel Diakomanolis Greece 14 292 1.3× 113 0.5× 57 0.3× 145 0.9× 52 0.4× 29 815
W. Frederick Sample United States 15 188 0.9× 133 0.6× 98 0.6× 286 1.8× 38 0.3× 20 864
Clara Bodelón United States 18 197 0.9× 98 0.5× 207 1.2× 244 1.5× 131 0.9× 41 975
John A. Maksem United States 17 192 0.9× 393 1.9× 84 0.5× 73 0.4× 17 0.1× 50 831
Peter Royce Australia 15 297 1.4× 239 1.1× 109 0.6× 39 0.2× 37 0.3× 35 791
Martin Young United Kingdom 13 142 0.7× 246 1.2× 137 0.8× 121 0.7× 38 0.3× 24 638
Rob F. M. Bevers Netherlands 15 649 3.0× 205 1.0× 161 0.9× 177 1.1× 14 0.1× 32 1.0k
M K Heatley United Kingdom 15 172 0.8× 72 0.3× 117 0.7× 170 1.0× 21 0.1× 48 690
M. Carrera Spain 19 385 1.8× 141 0.7× 210 1.2× 88 0.5× 241 1.7× 53 1.2k

Countries citing papers authored by Karin Hofmann

Since Specialization
Citations

This map shows the geographic impact of Karin Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Hofmann more than expected).

Fields of papers citing papers by Karin Hofmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Hofmann. The network helps show where Karin Hofmann may publish in the future.

Co-authorship network of co-authors of Karin Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Hofmann. A scholar is included among the top collaborators of Karin Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Hofmann. Karin Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Lenhard, Miriam, P Stieber, Linda Hertlein, et al.. (2011). The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses. Clinical Chemistry and Laboratory Medicine (CCLM). 49(12). 2081–8. 55 indexed citations
4.
Jackowski, Christian, et al.. (2011). Coronary thrombus and peracute myocardial infarction visualized by unenhanced postmortem MRI prior to autopsy. Forensic Science International. 214(1-3). e16–e19. 28 indexed citations
6.
Yoshimura, Toru, Rahul Patil, Gangamani S. Beligere, et al.. (2009). Development and analytical performance evaluation of an automated chemiluminescent immunoassay for pro-gastrin releasing peptide (ProGRP). Clinical Chemistry and Laboratory Medicine (CCLM). 47(12). 1557–63. 12 indexed citations
7.
Glodny, Bernhard, et al.. (2009). Normal kidney size and its influencing factors - a 64-slice MDCT study of 1.040 asymptomatic patients. BMC Urology. 9(1). 19–19. 120 indexed citations
8.
Glodny, Bernhard, et al.. (2009). A Right Accessory Renal Artery Arising from a Left Additional Common Renal Artery Stem. CardioVascular and Interventional Radiology. 32(4). 804–806. 3 indexed citations
9.
Glodny, Bernhard, Benjamin Henninger, Karin Hofmann, et al.. (2009). CT appearance of a patent impar umbilical artery in an adult woman and related anomalies: a case report and review of the literature. Cases Journal. 2(1). 65–65. 5 indexed citations
11.
Glodny, Bernhard, Johannes Petersen, Karin Hofmann, et al.. (2008). Kidney fusion anomalies revisited: clinical and radiological analysis of 209 cases of crossed fused ectopia and horseshoe kidney. British Journal of Urology. 103(2). 224–235. 118 indexed citations
12.
Kriegmair, M., Dorothea Nagel, Stefan Holdenrieder, et al.. (2003). Measurements of Complement Factor H-Related Protein (BTA-TRAK™ Assay) and Nuclear Matrix Protein (NMP22 Assay) – Useful Diagnostic Tools in the Diagnosis of Urinary Bladder Cancer?. Clinical Chemistry and Laboratory Medicine (CCLM). 41(1). 104–10. 31 indexed citations
13.
Stieber, P, et al.. (1999). Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.. PubMed. 19(4A). 2673–8. 72 indexed citations
14.
Kriegmair, M., Urban Schmitt, U Hasholzner, et al.. (1999). BTA-TRAK--a useful diagnostic tool in urinary bladder cancer?. PubMed. 19(4A). 2615–9. 30 indexed citations
15.
Reiter, W, et al.. (1998). Total and free PSA: a methodical and clinical evaluation of five assays.. PubMed. 17(6D). 4759–65. 3 indexed citations
16.
Stieber, P, et al.. (1997). CYFRA 21-1 quantity measurement in the urine of patients with carcinoma of the urinary bladder and tract.. PubMed. 17(4B). 3063–5. 6 indexed citations
17.
Stieber, P, et al.. (1997). Is PSA-ACT superior to total PSA in prostate cancer?. 2. 28. 1 indexed citations
18.
Wollenberg, Barbara, et al.. (1996). CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.. PubMed. 16(5B). 3117–24. 27 indexed citations
19.
Stieber, P, et al.. (1993). Comparison of Cytokeratin Fragment 19 (CYFRA 21-1), Tissue Polypeptide Antigen (TPA) and Tissue Polypeptide Specific Antigen (TPS) as Tumour Markers in Lung Cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 31(10). 689–94. 42 indexed citations
20.
Hofmann, Karin, et al.. (1972). Klinik und Therapie der Bromcarbamid -Vergiftung*. DMW - Deutsche Medizinische Wochenschrift. 97(49). 1911–1916. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026